drugset / Trial / NCT06552546

Pharmacokinetics of Single- and Double-dose Icodextrin

NCT06552546

Not yet recruiting 16 enrolled Peking University First Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study aims to provide the pharmacokinetics profiles of single- and double-dose icodextrin in patients on peritoneal dialysis (PD). It may expand the available knowledge of the clinical pharmacology of icodextrin following its intraperitoneal administration and fills the gaps in our understanding of the fate of icodextrin and the metabolic consequences of icodextrin and its metabolites.

Timeline

Start
2024-08-15
Primary completion
2025-03-30
Completion
2025-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Icodextrin Other / unclassified Other

Indications

No indication recorded.